RPC advises the shareholders of Axon on its sale to Medica

International law firm RPC has advised the shareholders of Axon Diagnostics, a UK-based teleradiology provider, on its sale to Medica Group, a market-leading provider of diagnostic services to the NHS and independent sector.

Axon, together with its sister company MITIS Health, will join Medica, marking an exciting new chapter for remote diagnostics in the UK. By combining their capabilities, they will become the UK's largest clinical reporting network, supporting more than 2.5 million patients each year across the majority of NHS Trusts.

With Medica's robust network of specialist clinicians and Axon's innovative technology solutions, together they can offer more capacity for clients across the nation, faster turnaround times for routine and urgent cases, and an enhanced experience for both healthcare partners and patients.  

The RPC team was led by Partner Jeremy Cunningham with support from Associates Catherine McLaughlin and Nick McKenzie, and the firm's M&A team. 

Commenting on the transaction, Jeremy Cunningham said: "We are very pleased to have supported the Axon shareholders on this significant transaction. It has been a pleasure to work with the brilliant team at Axon on a deal that will help deliver faster, high-quality diagnostic reporting for patients across the UK."

Rahul Mehta, CEO at Axon, said: "Axon was founded to push the boundaries of diagnostic innovation, and joining Medica enables us to amplify that mission. This merger combines our technology and agile approach with Medica's scale and clinical excellence, meaning more patients will benefit from faster and smarter reporting. We're excited to enter this next chapter together, bringing our teams and clients with us into the Medica Group as we continue building trusted, high-quality diagnostic services."

Client announcement: Axon Diagnostics joins Medica Group to enhance UK diagnostic services